Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Topical tofacitinib is effective and safe for treating alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Oral tofacitinib successfully treated total body hair loss in one patient.